An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
Regulatory alignment with U.S. Food and Drug Administration (FDA) on key elements of NOV-ERA Phase 2b study design, including novel primary ...
Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo treatment to a massive survival benefit versus late-day infusion in non-small cell ...
Agomab Therapeutics has announced the design of its phase 2b NOV‑ERA study of ontunisertib in fibrostenosing Crohn’s disease, following alignment with the US Food and Drug Administration on key ...
The findings suggest that Covid vaccines reduced the likelihood of severe illness last fall and winter.
US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...
A new study published in JMIR XR and Spatial Computing demonstrates that the way virtual reality therapeutics (VRx) are ...
Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced that the ReCET Clinical Study has reached full enrollment. A ...
6don MSN
Diffractive networks enable optical information transfer through random and unknown diffusers
The transmission of optical information through random scattering media is a major challenge in optics, biomedical imaging, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results